Revvity, Inc. (RVTY) Stock Grade

About Revvity, Inc.'s fundamentals

Revvity is a healthcare diagnostics and research company with a market capitalization of $16.8 billion, though its profitability metrics reveal some challenges relative to its valuation. The company is trading at a P/E ratio of 45.5, which is elevated compared to broader market averages, while its net profit margin of 8.5% and return on equity of just 3.3% suggest limited efficiency in converting revenue into profits. Revenue growth has been modest at 3.7% year-over-year, and the company returns minimal value to shareholders through dividends at a 0.3% yield.